365体育备用网址

图片

ライン

研究業績（学会抄録）

ライン

  1. Synthesis of deuterated benzyladenine and its application as a surrogate.
    Nkaelang Modutlwa, Hiroyuki Tada, Yoshiki Sugahara, Koichi Shiraki, Nobuyuki Hara, Yoshihiro Deyashiki, Takayuki Ando, Tomohiro Maegawa, Yasunari Monguchi, and Hironao Sajiki
    NUCLEIC ACIDS SYMP SER (OXF) (2009) 53: 105-106
  2. Alternative I-D exchange reaction on pyrimidine and purine nuclei mediated by tributyltin hydride using THF-d8 as a deuterium source.
    Tomonobu Mutsumi, Kazuo Maruhashi, Yasunari Monguchi, and Hironao Sajiki
    NUCLEIC ACIDS SYMP SER (OXF) (2009) 53: 3-4
  3. Modification of the sugar moiety in uridine via 2',3'-epoxyuridine derivatives.
    Takasu, Hideki; Tsuji, Yoshie; Sajiki, Hironao; Hirota, Kosaku. Laboratory of Medicinal Chemistry, Gifu Pharmaceutical University, 5-6-1 Mitahora-higashi, Gifu, Japan.
    Nucleic Acids Symposium Series (2004), 48, 49-50.
  4. Palladium-catalyzed H-D exchange into nucleic acids in deuterium oxide.
    Sajiki, Hironao; Aoki, Fumiyo; Esaki, Hiroyoshi; Maegawa, Tomohiro; Hirota, Kosaku. Laboratory of Medicinal Chemistry, Gifu Pharmaceutical University, Gifu, Japan.
    Nucleic Acids Research Supplement (2003), 3(3rd International Symposium on Nucleic Acids Chemistry [and] 30th Symposium on Nucleic Acids Chemistry in Japan, 2003), 55-56.
  5. A novel C-C bond formation at the 5-position of uridine derivatives.
    Sajiki, Hironao; Yamada, Akira; Yasunaga, Kanoko; Tsunoda, Takashi; Amer, Mumen F. A.; Hirota, Kosaku. Laboratory of Medicinal Chemistry, Gifu Pharmaceutical University, Gifu, Japan.
    Nucleic Acids Research Supplement (2002), 2(Twenty-ninth Symposium on Nucleic Acids Chemistry), 13-14.
  6. Synthesis of 2,3-dihydroinosine derivatives by reduction using BH3-THF.
    Hirota Kosaku; Hattori R; Sajiki Hironao; Monguchi Yasunari; Muraoka Osamu; Tanabe Genzo Gifu Pharmaceutical University, Mitahora-higashi, Gifu 502-8585, Japan
    Nucleic acids symposium series (2000), 44, 113-4.
  7. A novel C-C bond formation at the 5-position of uridine derivatives.
    Sajiki, Hironao; Yamada, Akira; Yasunaga, Kanoko; Tsunoda, Takashi; Amer, Mumen F. A.; Hirota, Kosaku. Laboratory of Medicinal Chemistry, Gifu Pharmaceutical University, Gifu, Japan.
    Nucleic Acids Research Supplement (2002), 2(Twenty-ninth Symposium on Nucleic Acids Chemistry), 13-14.
  8. Synthesis of 6-aminouracils and pyrrolo[2,3-d]pyrimidine-2,4-diones and their inhibitory effect on thymidine phosphorylase.
    Hirota Kosaku; Sawada Masayuki; Sajiki Hironao; Sako Magoichi Laboratory of Medicinal Chemistry, Gifu Pharmaceutical University, Japan
    Nucleic acids symposium series (1997), 37, 59-60.
  9. Synthesis of acyclonucleosides from purine nucleosides.
    Monguchi, Yasunari; Kitade, Kitade; Sajiki, Hironao; Sako, Magoichi; Hirota, Kosaku. Lab. Med. Chem., Gifu Pharmaceutical Univ., Gifu, Japan.
    Nucleic Acids Symposium Series (1996), 35(Twentythird Symposium on Nucleic Acids Chemistry, 1996), 51-52.
  10. Chemical modification of the sugar moiety in pyrimidine nucleosides via 2',3'-epoxy derivatives.
    Hirota, Kosaku; Tsuji, Yoshie; Ohkubo, Tomohiro; Takasu, Hideki; Kitade, Yukio; Sako, Magoichi; Sajiki, Hironao. Lab. Medicinal Chem., Gifu Pharmaceutical Univ., Gifu, Japan.
    Nucleic Acids Symposium Series (1996), 35(Twentythird Symposium on Nucleic Acids Chemistry, 1996), 47-48.
  11. Novel reactions of 5-bromouracil derivatives with active methylene compounds.
    Hirota, Kosaku; Sajiki, Hironao; Maki, Yoshifumi; Inoue, Hideo; Ueda, Tohru. Gifu Pharm. Univ., Gifu, Japan.
    Nucleic Acids Symposium Series (1986), 17(Symp. Nucleic Acids Chem., 14th, 1986), 9-12.
  12. Synthesis of 6-aminouracils and pyrrolo[2,3-d]pyrimidine-2,4-diones and their inhibitory effect on thymidine phosphorylase.
    Hirota Kosaku; Sawada Masayuki; Sajiki Hironao; Sako Magoichi Laboratory of Medicinal Chemistry, Gifu Pharmaceutical University, Japan
    Nucleic acids symposium series (1997), 37, 59-60.

TOP

Copyright (C) Organic Chemistry Laboratory (directed by Prof. Sajiki Hironao). All Rights Reserved.